Olmighty 20 H Tablet is a combination antihypertensive medication containing Hydrochlorothiazide 12.5 mg and Olmesartan Medoxomil 20 mg. Hydrochlorothiazide, a thiazide diuretic, promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal tubules of the kidneys, thereby reducing blood volume and lowering blood pressure. Olmesartan Medoxomil, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, leading to vasodilation and decreased aldosterone secretion, which further contributes to blood pressure reduction. The combination of these agents provides complementary mechanisms to effectively manage hypertension, improving blood pressure control in patients inadequately responsive to monotherapy. Olmighty 20 H is indicated for the treatment of essential hypertension to reduce the risk of cardiovascular events such as stroke and myocardial infarction. It should be used under medical supervision, with monitoring of renal function, electrolytes, and blood pressure. Caution is advised in patients with renal or hepatic impairment, electrolyte imbalances, or hypersensitivity to sulfonamides. Common side effects may include dizziness, hypotension, electrolyte disturbances, and gastrointestinal discomfort. This medication is contraindicated during pregnancy and lactation. Adherence to prescribed dosage and regular follow-up are essential for optimal therapeutic outcomes.